IL-6 were evaluated by qRT-PCR using protocols and primers described in (18).
119
Presence of apoptotic cells was determined by in situ TUNEL as in (17).
120
Liver fibrosis: liver sections were stained for collagen deposition (Masson's 121 trichrome) and the extent of fibrosis estimated from relative area of collagen-staining 122 respect to liver area, as we described in (17). Hydroxyproline was determined by 123 photometry in liver hydrolysates as in (20) . mRNA levels of collagen type I (Col1A)
124
and transforming growth factor β (TGFβ) were determined by qRT-PCR using primers 125 described in (10).
126
Isolation and transfection of liver sinusoid endothelial cells (LSECs): LSECs were 127 isolated by collagenase perfusion, iodixanol-density-gradient centrifugation and 128 centrifugal elutriation as in (21). Viability was >95%, purity >98% based on uptake of 129 formaldehyde-treated albumin, a function specific to LSECs (4). siRNA oligonucleotides 130 for TRPC3, 6 or 7 (siGENOME-SMART-pool, Dharmacon) were delivered to LSECs 131 with Lipofectamine2000 (Invitrogen, CA), 100 nM final concentration (as in (16) (not shown). In agreement with our previous findings (17), after 10 weeks on HFD there were no differences in the already hyperlipidemic profile of the two groups of animals 163 (Table I) (Table I) . H&E staining revealed scattered inflammatory 175 infiltration (score: 1.38 ± 0.32 vs. 0.51 ± 0.21, for TgESTRPC3/ApoeKO vs. non-
176
Tg/ApoeKO, respectively; p<0.01, n=8). Levels of the inflammatory genes TNFα, IL-1β 177 and IL-6 were augmented by 2.3-, 3.1-and 2.8-fold respectively, in livers from 178 TgESTRPC3/ApoeKO vs. non-Tg/ApoeKO mice (n=5, P<0.01).
179
Next we examined whether the livers of TgESTRPC3/ApoeKO mice showed evidence 180 of fibrosis. Figure 3 shows that already after 10 weeks on HFD there is collagen 181 deposition in livers from TgESTRPC3/ApoeKO mice, but not in non-Tg/ApoeKO mice 182 (Fig. 3, upper panels) . The fibrosis augmented and was more disseminated by 16 183 weeks on HFD (Fig. 3, lower panels) , i.e., as aortic atherosclerosis progressed. Hepatic (9, 13, 14) . In this context, the outcome of our studies is 229 also especially interesting, as we observe progression from NAFLD to NASH with row of values) and the indicated parameters were measured as described in Methods.
348
Values are mean ± SEM, n=10 mice. Non-esterified fatty acids (mmol/l) 1.3 ± 0.6 1.1 ± 0.8
1.5 ± 0.7 1.6 ± 0.5 Body weight before diet (g) 10 weeks on high fat diet 16 weeks on high fat diet 19.5 ± 1.0 28.7 ± 2.2 29.4 ± 1.2 18.2 ± 1.1 27.7 ± 1.8 29.6 ± 2.0 
